MindWalk Corp.

HYFT | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.48

+$0.01 (+0.68%)

Sep 22, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.68%

(1D)

Rating

Updated: Sep 9, 2026

31.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $69.54M

1D Range

1.41 1.50

52W Range

0.99 2.99

Valuation (TTM)

PE -5.50

PB 14.00

EV/EBITDA -5.56

Valuation (NTM)

Forward PE N/A

Forward PEG 0.22

Price Target $5

Cash Flow

FCF Yield -13.0%

SBC Adj. FCF Yield -13.2%

SBC Impact -1.2%

Margins

Gross Margin 60.8%

Operating Margin -104.4%

FCF Margin -77.9%

Growth (CAGR)

Revenue 3Y | 5Y -9.3% | -2.9%

Dil EPS 3Y | 5Y 41.9% | 15.6%

FCF 3Y | 5Y -30.8% | 19.2%

Returns

ROA -98.5%

ROE -144.3%

ROIC -149.5%

Financial Health

Net Cash

C$7.14M ($5.1M)

Current Ratio 1.84

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated la...

Sector Healthcare

Industry Biotechnology

Employees 76

IPO Date Jan 6, 2002

Website www.mindwalkai.com

Fiscal Year May - April

Full Company Profile

Latest News

No news articles available yet.

Earnings

Latest Earnings

Sep 14, 2026

EPS

-$0.09

Miss -73.18%

YoY: -28.57%

REV

$2.73M

Miss -15.25%

YoY: -50.17%

Next Earnings

Dec 21, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+237.84%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞